Identification of high‐risk patients admitted to intensive care with COVID‐19 may inform
management strategies. The objective of this meta‐analysis was to determine factors …

Abstract Coronavirus disease 2019 (COVID‐19) caused by infection with severe acute
respiratory syndrome coronavirus 2 was first detected in Wuhan, China, in late 2019 and …

SARS‐CoV‐2 infection causes broad‐spectrum immunopathological disease, exacerbated
by inflammatory co‐morbidities. A better understanding of mechanisms underpinning virus …

Despite tremendous progress in the understanding of COVID-19, mechanistic insight into
immunological, disease-driving factors remains limited. We generated maVie16, a mouse …

Understanding factors associated with disease severity and mortality from coronavirus
disease (COVID-19) was critical for effective risk stratification. We aimed to investigate the …

Although studies have shown severe Coronavirus disease 2019 (COVID-19) outcomes in
patients with pre-existing coronary heart disease (CHD), the prognosis of COVID-19 patients …

The SARS-CoV-2 virus has caused a catastrophic impact on the world for the past 3 years.
The virus has now returned with the emergence of the Omicron (B. 1.1. 529) variant. Within …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
virus that belongs to the coronaviruses and causes coronavirus disease 2019 (COVID-19) …

Background COVID-19 mortality studies have primarily focused on persons aged≥ 65
years; less is known about decedents aged< 65 years. Methods We conducted a case …

Objective To describe the frequency of neuropsychiatric complications among hospitalized
patients with coronavirus disease 2019 (COVID-19) and their association with pre-existing …